Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial

Show other versions (1)

Background: Patients with ischaemic stroke or transient ischaemic attack (TIA) are at high risk of recurrent stroke or other cardiovascular events. We compared the selective thromboxane-prostaglandin receptor antagonist terutroban with aspirin in the prevention of cerebral and cardiovascular ischaem...

Full description

Bibliographic Details
Main Authors:	Bousser, M, Amarenco, P, Chamorro, A, Fisher, M, Ford, I, Fox, K, Hennerici, MG, Mattle, H, Rothwell, P, De Cordoüe, A, Fratacci, M
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
by: Bousser, MG, et al.
Published: (2011)

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
by: Bousser, MG, et al.
Published: (2009)

The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
by: Bousser, MG, et al.
Published: (2009)

Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population.
by: Fox, K, et al.
Published: (2013)

Heart rate is a prognostic risk factor for myocardial infarction: A post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history of ischemic strOke or tRansient ischeMic attack) study population
by: Fox, K, et al.
Published: (2013)

Rationale, design and patients' baseline characteristics of the PERFORM study
by: Bousser, MG, et al.
Published: (2009)

The Intracranial-B2LEED3S score and the risk of intracranial hemorrhage in ischemic stroke patients under antiplatelet treatment.
by: Amarenco, P, et al.
Published: (2017)

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.
by: Rothwell, P, et al.
Published: (2011)

Medical treatment in acute and long-term secondary prevention after transient ischaemic attach and ischaemic stroke
by: Rothwell, P, et al.
Published: (2011)

Specificities of ischemic stroke risk factors in Arab-speaking countries
by: Abboud, H, et al.
Published: (2017)

Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
by: Yongjun Wang, et al.
Published: (2023-10-01)

Aspirin and transient ischaemic attacks.
by: Peto, R, et al.
Published: (1979)

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
by: Rothwell, PM, et al.
Published: (2016)

Immediate aspirin for suspected ischaemic stroke.
by: Baigent, C, et al.
Published: (1999)

Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naive patients in the acute phase after TIA or minor ischaemic stroke.
by: Geraghty, O, et al.
Published: (2010)

Atherothrombosis and ischaemic stroke.
by: Rothwell, P
Published: (2007)

Atherothrombosis and ischaemic stroke
by: Rothwell, P
Published: (2007)

Effects on colon cancer risk in randomised trials of aspirin
by: Rothwell, P
Published: (2011)

Apolipoproteins predict ischaemic stroke in patients with a previous transient ischaemic attack
by: Bhatia, M, et al.
Published: (2004)

Recent advances in management of transient ischaemic attacks and minor ischaemic strokes.
by: Rothwell, P, et al.
Published: (2006)

Aspirin in the prevention of cancer Reply
by: Rothwell, P
Published: (2011)

Low birthweight and ischaemic heart disease.
by: Rothwell, P
Published: (1994)

Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
by: Yongjun Wang, et al.

Comparison of Different Laboratory Tests to Identify “Aspirin Resistance” and Risk of Vascular Events among Ischaemic Stroke Patients: A Double-Blind Study
by: Narayanaswamy Venketasubramanian, et al.
Published: (2022-05-01)

Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack.
by: Bhatia, M, et al.
Published: (2006)

Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease
by: Niyata Hananta Karunawan, et al.
Published: (2021-12-01)

Comparison of effectiveness of aspirin, clopidogrel and cilostazol monotherapy treatment in ischaemic stroke
by: Endarwati Tuti, et al.
Published: (2025-01-01)

Familiar frequency of ischaemic stroke and transient ischaemic attack in relation to clinical subtype and intermediate phenotypes
by: Rothwell, P, et al.
Published: (2001)

Transient ischaemic attacks: time to wake up.
by: Rothwell, P
Published: (2007)

Thromboxane–prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats
by: David Lagier, et al.
Published: (2019-02-01)

Indications for early aspirin use in acute ischaemic stroke: A combined analysis of over 40,000 randomised patients
by: Chen, Z, et al.
Published: (1999)

Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke
by: Arnarsdottir Lola, et al.
Published: (2012-08-01)

CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
by: Chen, Z, et al.
Published: (1997)

Paramedics should delay giving aspirin to patients with stroke.
by: Ward, M, et al.
Published: (2000)

Genetic epidemiology of ischaemic stroke
by: Flossmann, E, et al.
Published: (2004)

The need for emergency treatment of TIA and "minor" ischaemic stroke
by: Rothwell, P
Published: (2005)

Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention.
by: Markus, H, et al.
Published: (2013)

Asymptomatic recurrent cerebral ischaemic lesions on diffusion-weighted imaging in the subacute and chronic phase after transient ischaemic attack or minor ischaemic stroke.
by: Mazzucco, S, et al.
Published: (2007)

Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study.
by: Chinnery, P, et al.
Published: (2010)

Alternate-day, low-dose aspirin and cancer risk.
by: Rothwell, P
Published: (2013)